LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 73

Search options

  1. Article ; Online: Industry Payments to Physicians and the Public's Right to Know About Them.

    Lichter, Paul R

    JAMA ophthalmology

    2018  Volume 136, Issue 12, Page(s) 1381–1382

    MeSH term(s) Health Expenditures ; Humans ; Industry ; Ophthalmology ; Physicians
    Language English
    Publishing date 2018-09-18
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2701705-9
    ISSN 2168-6173 ; 2168-6165
    ISSN (online) 2168-6173
    ISSN 2168-6165
    DOI 10.1001/jamaophthalmol.2018.4163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Small Payments, Large Consequences.

    Shtein, Roni M / Lichter, Paul R / Lee, Paul P

    JAMA ophthalmology

    2022  Volume 140, Issue 9, Page(s) 862–863

    MeSH term(s) Drug Industry ; Humans ; United States
    Language English
    Publishing date 2022-07-28
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2701705-9
    ISSN 2168-6173 ; 2168-6165
    ISSN (online) 2168-6173
    ISSN 2168-6165
    DOI 10.1001/jamaophthalmol.2022.2763
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.

    Lichter, Paul R

    JAMA ophthalmology

    2016  Volume 134, Issue 8, Page(s) 903–904

    MeSH term(s) Angiogenesis Inhibitors ; Bevacizumab ; Ophthalmologists ; Ranibizumab ; Receptors, Vascular Endothelial Growth Factor ; Vascular Endothelial Growth Factor A
    Chemical Substances Angiogenesis Inhibitors ; Vascular Endothelial Growth Factor A ; Bevacizumab (2S9ZZM9Q9V) ; Receptors, Vascular Endothelial Growth Factor (EC 2.7.10.1) ; Ranibizumab (ZL1R02VT79)
    Language English
    Publishing date 2016-06-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2701705-9
    ISSN 2168-6173 ; 2168-6165
    ISSN (online) 2168-6173
    ISSN 2168-6165
    DOI 10.1001/jamaophthalmol.2016.1794
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Implications of the Sunshine Act--revelations, loopholes, and impact.

    Lichter, Paul R

    Ophthalmology

    2015  Volume 122, Issue 4, Page(s) 653–655

    MeSH term(s) Centers for Medicare and Medicaid Services (U.S.)/statistics & numerical data ; Drug Industry/economics ; Gift Giving ; Humans ; Ophthalmology/economics ; Patient Protection and Affordable Care Act/legislation & jurisprudence
    Language English
    Publishing date 2015-04
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 392083-5
    ISSN 1549-4713 ; 0161-6420
    ISSN (online) 1549-4713
    ISSN 0161-6420
    DOI 10.1016/j.ophtha.2014.12.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Payment data and the "me" in Medicare.

    Lichter, Paul R

    Ophthalmology

    2014  Volume 121, Issue 10, Page(s) 1849–1851

    MeSH term(s) Humans ; Income ; Medicare ; Ophthalmology ; United States
    Language English
    Publishing date 2014-10
    Publishing country United States
    Document type Editorial
    ZDB-ID 392083-5
    ISSN 1549-4713 ; 0161-6420
    ISSN (online) 1549-4713
    ISSN 0161-6420
    DOI 10.1016/j.ophtha.2014.07.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Interview with Paul R. Lichter, MD. Interwed by George B Bartley.

    Lichter, Paul R

    Archives of ophthalmology (Chicago, Ill. : 1960)

    2012  Volume 130, Issue 9, Page(s) 1205–1206

    MeSH term(s) Humans ; Leadership ; Ophthalmology ; Physician Executives ; United States
    Language English
    Publishing date 2012-09
    Publishing country United States
    Document type Interview ; Portraits
    ZDB-ID 211580-3
    ISSN 1538-3601 ; 0003-9950 ; 0093-0326
    ISSN (online) 1538-3601
    ISSN 0003-9950 ; 0093-0326
    DOI 10.1001/archophthalmol.2012.1954
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database.

    Slentz, Dane H / Nelson, Christine C / Lichter, Paul R

    JAMA ophthalmology

    2019  Volume 137, Issue 9, Page(s) 1038–1044

    Abstract: Importance: An increased awareness of the interactions between the medical industry and health care professionals may lead to lower health care costs and more effective health care practices.: Objective: To assess the characteristics of industry ... ...

    Abstract Importance: An increased awareness of the interactions between the medical industry and health care professionals may lead to lower health care costs and more effective health care practices.
    Objective: To assess the characteristics of industry payments made to ophthalmologists between 2013 and 2017.
    Design, setting, and participants: This analysis included data reported in the June 29, 2018, update of the Centers for Medicare & Medicaid Services Open Payments Database (OPD). The OPD contains public records of industry payments made to physicians and teaching hospitals from August 1, 2013, to December 31, 2017, as reported by the medical industry. All general or research payments distributed to US ophthalmologists and contained in the OPD were included in this study. Data are summarized by practitioner, manufacturer, payment category, and geographic location.
    Main outcomes and measures: Main outcomes were the distribution, quantity, and value of payments made to ophthalmologists practicing in the United States or US territories. The financial characteristics of payment category, manufacturer, product, and location were also assessed.
    Results: This analysis revealed that the OPD showed industry reporting a total of 20 943 ophthalmologists receiving 736 517 payments worth $543 679 603.53 (1.67% of all industry-reported funds in the OPD). The median payment value was $22.44. Most payments were for food and beverages (581 588 [78.96%]), whereas most funds were allocated toward research ($310 142 151.88 [57.05%]) and consulting fees ($73 565 327.71 [13.51%]). The median payout to each ophthalmologist was $637.75 (interquartile range, $167.33-$2065.54). California was the highest-grossing state, receiving $101 135 980.34 (18.60%) of all payments. Fifteen companies were responsible for 87.68% of all funds distributed ($476 719 470.11) and were mostly involved in the production of pharmaceutical agents (anti-vascular endothelial growth factor agents, glaucoma eyedrops, and ocular lubricants) and surgical devices (cataract and glaucoma).
    Conclusions and relevance: Although there is no way to know the veracity of these reports, the findings suggest the financial ophthalmologist-industry relationship is substantial. These relationships may be adding to health care costs and affecting the quality of care, although those associations were not evaluated in this study.
    Language English
    Publishing date 2019-07-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701705-9
    ISSN 2168-6173 ; 2168-6165
    ISSN (online) 2168-6173
    ISSN 2168-6165
    DOI 10.1001/jamaophthalmol.2019.2456
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Physician-Industry Financial Relationships, Key Opinion Leader Status, and Program Visibility.

    Horstman, Alyssa A / Niziol, Leslie M / Shedden, Kerby / Chimonas, Susan / Lichter, Paul R

    Ophthalmology

    2021  Volume 129, Issue 4, Page(s) 463–465

    MeSH term(s) Conflict of Interest ; Drug Industry ; Humans ; Leadership ; Physicians
    Language English
    Publishing date 2021-10-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 392083-5
    ISSN 1549-4713 ; 0161-6420
    ISSN (online) 1549-4713
    ISSN 0161-6420
    DOI 10.1016/j.ophtha.2021.10.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Association of Mandatory Disclosure Policies and Laws With Physician-Industry Financial Relationships.

    Horstman, Alyssa A / Niziol, Leslie M / Chimonas, Susan / Lichter, Paul R

    JAMA ophthalmology

    2019  Volume 137, Issue 5, Page(s) 523–530

    Abstract: Importance: Beside the goal of increasing transparency to the public, disclosure policies and laws have been established with a goal to also reduce ethically questionable financial relationships between physicians and the medical industry. Data on these ...

    Abstract Importance: Beside the goal of increasing transparency to the public, disclosure policies and laws have been established with a goal to also reduce ethically questionable financial relationships between physicians and the medical industry. Data on these relationships should be reviewed to understand the association between these policies and laws and the attainment of reduced relationships.
    Objective: To assess whether disclosure policies and laws have been associated with a decrease in financial disclosure reporting by physicians.
    Design, setting, and participants: This cross-sectional study uses yearly data from 2008 through 2015 from the participants in the American Academy of Ophthalmology's Annual Meeting. Trends in financial disclosures over time were investigated for the association of disclosure policies and laws with potentially beneficial, as well as ethically questionable physician-industry ties. Linear regression models were used to estimate the annual change in financial disclosures and are reported with 95% CIs.
    Exposures: Disclosure policies and laws.
    Main outcomes and measures: The annual aggregate financial disclosures by type (ie, consultant, lecturer, employee, grant support, equity owner, patent holder).
    Results: Financial disclosures increased from 3966 in 2008 to 5266 in 2015 (P < .001). The number of disclosures reported in the categories consultant, equity owner, patents, and grant support all increased from 2008 to 2015 (consultant disclosures, 121 [95% CI, 88-155] per year; P < .001; equity owner disclosures, 32 [95% CI, 22-42] per year; P < .001; patent disclosures, 19 [95% CI, 13-26] per year; P < .001; grant support disclosures, 78 [95% CI, 48-107] per year; P < .001), while the employee and lecturer categories did not change significantly. The percentage of financial disclosures in the lecturer category decreased relative to the total (estimate, -1.1% [95% CI, -1.3% to -0.8%] per year; P < .001), owing to the number of financial disclosures for this category remaining stable while most other types increased.
    Conclusions and relevance: Disclosure was not associated with a chilling effect (decrease in financial disclosures associated with potentially beneficial physician-industry ties). Disclosure was associated with a possible disinfecting effect, whereby the percentage of ethically questionable disclosures (ie, lecturers) decreased, although the frequency remained stable. A permissive effect (physicians becoming more inclined to having industry relationships) was also observed. Thus, disclosure rules should be enhanced or alternative approaches to disclosure reconsidered to promote a decrease in ethically questionable relationships.
    MeSH term(s) Conflict of Interest ; Cross-Sectional Studies ; Disclosure/legislation & jurisprudence ; Disclosure/standards ; Disclosure/statistics & numerical data ; Humans ; Industry ; Physicians ; United States
    Language English
    Publishing date 2019-02-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2701705-9
    ISSN 2168-6173 ; 2168-6165
    ISSN (online) 2168-6173
    ISSN 2168-6165
    DOI 10.1001/jamaophthalmol.2019.0085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: CME, physicians, and Pavlov: can we change what happens when industry rings the bell?

    Lichter, Paul R

    Transactions of the American Ophthalmological Society

    2009  Volume 106, Page(s) 39–43; discussion 44–5

    Abstract: Purpose: To show how physicians' conditioned response to "keeping up" has helped industry's opportunistic funding of continuing medical education (CME) and to propose ways to counter the conditioned response to the benefit of patients and the public.: ...

    Abstract Purpose: To show how physicians' conditioned response to "keeping up" has helped industry's opportunistic funding of continuing medical education (CME) and to propose ways to counter the conditioned response to the benefit of patients and the public.
    Methods: Review of the literature and commentary on it.
    Results: The pharmaceutical and device industries (hereafter referred to as industry) have a long history of bribing physicians to prescribe and use their products. Increasing pressure from Congress and the public has been brought to bear on industry gifting. This pressure, coinciding with increasing financial problems for the providers of CME, provided industry with reason and opportunity to expand its role in the financing of CME. Industry's incentive to make its CME funding appear to be an arm's-length transaction has spawned medical education service supplier (MESS) companies. Industry makes "unrestricted grants" to the MESS, and the MESS puts on the CME program. Helped by these CME programs, industry is able to subtly "buy" physicians one at a time, so that under the cover of "education" they and their academic institutions and medical organizations lose sight of being CME pawns in industry's sole objective: profit.
    Conclusions: Despite a vast literature showing how physician integrity is easy prey to industry, the medical profession continues to allow industry to have a detrimental influence on the practice of medicine and on physician respectability. It will take resolute action to change the medical profession's conditioned response to industry's CME bell and its negative effect on patients and the public.
    MeSH term(s) Accreditation ; Conflict of Interest ; Drug Industry/ethics ; Education, Medical, Continuing/economics ; Education, Medical, Continuing/ethics ; Ethics, Medical ; Financial Support ; Humans ; Ophthalmology/ethics ; Physicians/ethics ; United States
    Language English
    Publishing date 2009-03-10
    Publishing country United States
    Document type Duplicate Publication ; Journal Article
    ZDB-ID 391375-2
    ISSN 1545-6110 ; 0065-9533
    ISSN (online) 1545-6110
    ISSN 0065-9533
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top